Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2005 5
2006 6
2007 2
2008 2
2009 1
2010 1
2011 3
2012 1
2013 1
2014 3
2015 4
2016 2
2019 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
UK recommendations for HER2 assessment in breast cancer: an update.
Rakha EA, Tan PH, Quinn C, Provenzano E, Shaaban AM, Deb R, Callagy G, Starczynski J, Lee AHS, Ellis IO 1, Pinder SE. Rakha EA, et al. Among authors: starczynski j. J Clin Pathol. 2023 Apr;76(4):217-227. doi: 10.1136/jcp-2022-208632. Epub 2022 Dec 23. J Clin Pathol. 2023. PMID: 36564170 Review.
Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.
Zaakouk M, Van Bockstal M, Galant C, Callagy G, Provenzano E, Hunt R, D'Arrigo C, Badr NM, O'Sullivan B, Starczynski J, Tanchel B, Mir Y, Lewis P, Shaaban AM. Zaakouk M, et al. Among authors: starczynski j. Cancers (Basel). 2023 Feb 28;15(5):1511. doi: 10.3390/cancers15051511. Cancers (Basel). 2023. PMID: 36900303 Free PMC article.
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Katayama A, Starczynski J, Toss MS, Shaaban AM, Provenzano E, Quinn CM, Callagy G, Purdie CA, Millican-Slater R, Purnell D, Chagla L, Oyama T, Pinder SE, Chan S, Ellis I, Lee AHS, Rakha EA. Katayama A, et al. Among authors: starczynski j. Histopathology. 2022 Oct;81(4):511-519. doi: 10.1111/his.14728. Epub 2022 Aug 8. Histopathology. 2022. PMID: 35879836 Free PMC article.
FKBPL: a marker of good prognosis in breast cancer.
Nelson L, McKeen HD, Marshall A, Mulrane L, Starczynski J, Storr SJ, Lanigan F, Byrne C, Arthur K, Hegarty S, Ali AA, Furlong F, McCarthy HO, Ellis IO, Green AR, Rakha E, Young L, Kunkler I, Thomas J, Jack W, Cameron D, Jirström K, Yakkundi A, McClements L, Martin SG, Gallagher WM, Dunn J, Bartlett J, O'Connor D, Robson T. Nelson L, et al. Among authors: starczynski j. Oncotarget. 2015 May 20;6(14):12209-23. doi: 10.18632/oncotarget.3528. Oncotarget. 2015. PMID: 25906750 Free PMC article.
An international study to increase concordance in Ki67 scoring.
Polley MY, Leung SC, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JM, McShane LM, Enos RA, Badve SS, Bane AL, Borgquist S, Fineberg S, Lin MG, Gown AM, Grabau D, Gutierrez C, Hugh JC, Moriya T, Ohi Y, Osborne CK, Penault-Llorca FM, Piper T, Porter PL, Sakatani T, Salgado R, Starczynski J, Lænkholm AV, Viale G, Dowsett M, Hayes DF, Nielsen TO. Polley MY, et al. Among authors: starczynski j. Mod Pathol. 2015 Jun;28(6):778-86. doi: 10.1038/modpathol.2015.38. Epub 2015 Feb 20. Mod Pathol. 2015. PMID: 25698062 Free article.
Updated UK Recommendations for HER2 assessment in breast cancer.
Rakha EA, Pinder SE, Bartlett JM, Ibrahim M, Starczynski J, Carder PJ, Provenzano E, Hanby A, Hales S, Lee AH, Ellis IO; National Coordinating Committee for Breast Pathology. Rakha EA, et al. Among authors: starczynski j. J Clin Pathol. 2015 Feb;68(2):93-9. doi: 10.1136/jclinpath-2014-202571. Epub 2014 Dec 8. J Clin Pathol. 2015. PMID: 25488926 Free PMC article.
42 results